Company intelligence / Profile preview

Allcyte

Vienna, Austria

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Allcyte developed a clinically validated ex vivo functional precision oncology platform ('pharmacoscopy') that tests large panels of drugs on live patient cancer samples to guide treatment selection and support pre-clinical drug discovery; results from a Medical University of Vienna trial in aggressive late-stage blood cancers showed treatment recommendations were feasible and associated with high response rates in heavily pretreated patients.

Therapeutic areas: Oncology
Industry: Drug Discovery Services

Partnerships

Boehringer IngelheimMultiple (≈10) large pharmaceutical companies using the platform for drug discovery partnerships

Beyond the preview

Go deeper on Allcyte.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allcyte.

Explore the full profile